心導管電氣燒灼術市場規模、佔有率和成長分析（按產品類型、方法、應用、最終用途和地區）- 產業預測 2025-2032

2023 年全球心導管電氣燒灼術市場規模價值 41 億美元，預計將從 2024 年的 46.6 億美元成長到 2032 年的 129.2 億美元，預測期內（2025-2032 年）的複合年成長率為 13.6%。

心臟疾病率上升的原因是咖啡因消費量的增加、久坐的生活方式、高酒精和菸草使用率以及藥物濫用。世界衛生組織（WHO）透露，菸草相關心臟病每年導致190多萬人死亡，美國心臟協會（AHA）指出，吸菸是美國約20%死亡的原因，約80萬人死於心血管問題。在心導管電氣燒灼術領域，儘管由於醫療中斷導致 COVID-19 疫情期間遭遇挫折，但持續的技術創新和人們對消融設備的認知不斷提高正在推動市場成長。各國政府正在實施支持措施，主要企業正在採取新策略來增強穩定性和擴張性，特別是因為心律不整是由多種健康和生活方式因素造成的。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管分析
• 專利分析

心導管電氣燒灼術市場規模（按產品類型和複合年成長率） (2025-2032)

• 市場概況
• 射頻 (RF) 消融儀
  • 溫控射頻消融
  • 液體冷卻射頻消融器
  • 機器人導管操作系統
• 電燒灼
  • 氬氣等離子/束凝固設備
  • 不可逆電穿孔消融器
• 冷凍消融裝置
  • 組織接觸探針
  • 組織噴霧探針
• 超音波消融器
  • 高強度聚焦超音波消融儀
  • 磁振造影引導聚焦超音波消融
  • 超音波消融系統
• 微波消融
  • 微波熱療裝置

心導管電氣燒灼術市場規模（依方法和複合年成長率） (2025-2032)

• 市場概況
• 導管底座
• 開放性手術/外科手術

心導管電氣燒灼術市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 心房顫動和心房撲動
• 心搏過速
• 其他

心導管電氣燒灼術市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 門診手術中心
• 心臟中心
• 其他

心導管電氣燒灼術市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Medtronic（United States）
• Biosense Webster（a subsidiary of Johnson & Johnson）（United States）
• Boston Scientific Corporation（United States）
• Abbott Laboratories（United States）
• AtriCure, Inc.（United States）
• MicroPort Scientific Corporation（China）
• Biotronik SE & Co. KG（Germany）
• Stereotaxis, Inc.（United States）
• Osypka Medical GmbH（Germany）
• Alcon Laboratories Inc.（United States）

結論和建議

Global Cardiac Ablation Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.66 billion in 2024 to USD 12.92 billion by 2032, growing at a CAGR of 13.6% during the forecast period (2025-2032).

The rising prevalence of cardiac disorders is driven by increased caffeine consumption, sedentary habits, and high rates of alcohol and tobacco use, alongside substance misuse. The World Health Organization highlights that tobacco-related heart diseases cause over 1.9 million deaths annually, while the American Heart Association links nearly 800,000 U.S. deaths to cardiovascular issues, with 20% caused by smoking. Despite setbacks in the Cardiac Ablation sector during the COVID-19 pandemic due to healthcare disruptions, ongoing technological innovations and increased awareness of ablation devices are facilitating market growth. Governments are implementing supportive measures, and leading companies are adopting novel strategies to enhance stabilisation and expansion, particularly as cardiac arrhythmia stems from various health and lifestyle factors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Ablation Market Segments Analysis

Global Cardiac Ablation Market is segmented by Product Type, Approach, Application, End-use and region. Based on Product Type, the market is segmented into Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators and Microwave Ablators. Based on Approach, the market is segmented into Catheter-based and Open/Surgical. Based on Application, the market is segmented into Atrial Fibrillation & Flutter, Tachycardia and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Cardiac Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Ablation Market

The global cardiac ablation market is being significantly propelled by advancements in technology, which are improving the efficacy and safety of ablation procedures. These innovations not only inspire confidence in patients seeking treatment but also encourage healthcare professionals to adopt these enhanced methods. As a result, both parties are increasingly drawn to the benefits of modern cardiac ablation techniques, creating a robust demand and expanding the market's potential. Consequently, the integration of cutting-edge technologies continues to play a crucial role in shaping the future landscape of cardiac care, thereby driving growth within the global cardiac ablation sector.

Restraints in the Global Cardiac Ablation Market

The global cardiac ablation market may face significant limitations due to the requirement for specialized training in performing cardiac ablation procedures. A lack of adequately trained professionals can impede the growth of this market, as the effectiveness and safety of these procedures greatly depend on skilled practitioners. As the demand for such innovative medical treatments increases, addressing the shortage of qualified personnel becomes crucial. Without an adequate supply of skilled experts, the potential for market expansion could be stunted, ultimately affecting patient outcomes and healthcare advancements in the field of cardiac care.

Market Trends of the Global Cardiac Ablation Market

The Global Cardiac Ablation market is experiencing a significant trend towards minimally invasive procedures, driven by an increasing preference among both patients and healthcare providers for techniques that minimize discomfort and optimize recovery. These innovative methods not only reduce hospital stays but also enhance overall patient experiences by shortening recovery times, leading to quicker returns to daily activities. As advancements in technology continue to emerge, the shift towards such procedures is expected to accelerate, thereby fostering market growth and expanding patient access to effective treatment options for cardiac issues, while also aligning with broader healthcare movements prioritizing patient-centric care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Analysis
• Patent Analysis

Global Cardiac Ablation Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Radiofrequency (RF) Ablators
  • Temperature-Controlled Radiofrequency Ablators
  • Fluid-Cooled Radiofrequency Ablators
  • Robotic Catheter Manipulation Systems
• Electrical Ablators
  • Argon Plasma/Beam Coagulators
  • Irreversible Electroporation Ablators
• Cryoablation Devices
  • Tissue Contact Probes
  • Tissue Spray Probes
• Ultrasound Ablators
  • High-Intensity Focused Ultrasound Ablators
  • Magnetic Resonance Guided Focused Ultrasound Ablators
  • Ultrasound Ablation Systems
• Microwave Ablators
  • Microwave Thermotherapy Devices

Global Cardiac Ablation Market Size by Approach & CAGR (2025-2032)

• Market Overview
• Catheter-based
• Open/Surgical

Global Cardiac Ablation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Atrial Fibrillation & Flutter
• Tachycardia
• Others

Global Cardiac Ablation Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• Others

Global Cardiac Ablation Market Size & CAGR (2025-2032)

• North America (Product Type, Approach, Application, End-use)
  • US
  • Canada
• Europe (Product Type, Approach, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Approach, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Approach, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Approach, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosense Webster (a subsidiary of Johnson & Johnson) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stereotaxis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka Medical GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Laboratories Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations